FDA Drug Application (050461) for ANCEF by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number050461
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameANCEF
Active IngredientCEFAZOLIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient CEFAZOLIN SODIUM8


Back to FDA Applications sponsored by GLAXOSMITHKLINE